Drug Discovery Informatics Market

Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Molecular Docking, Library Preparation), Solution (Software, Services), End User (Pharmaceutical & Biotechnology, Contract Research Organization) - Global Forecast to 2022

Report Code: HIT 5838 Dec, 2017, by marketsandmarkets.com

[115 Pages Report] The global drug discovery informatics market is projected to reach USD 2.84 Billion in 2022 from USD 1.50 Billion in 2016, at CAGR of 11.2% during forecast period. The base year considered for the study is 2016, and the forecast for the market size is provided for the period between 2017 and 2022. In the current market scenario, there is a growing demand for discovery informatics solutions. The major factors driving the growth of the global market include the rising R&D expenditure, the increasing focus on drug discovery, and need to control the drug discovery and development cost. On the other hand, the scarcity of skilled professionals, and high pricing and setup cost of informatics software are the major factors restraining the growth of this market.

Objectives of the Study

  • To define, describe, and forecast the global market on the basis of function, solution, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW)
  • To profile the key players in the market and comprehensively analyze their market positions and core competencies
  • To track and analyze competitive developments such as partnerships, agreements, and acquisitions; new product developments; and research and development activities in the global market

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global drug discovery informatics market and estimate the size of various other dependent submarkets. Major players in the market were identified through secondary research and their market presence was studied through primary and secondary research. Secondary research included the study of the annual and financial reports of top market players, white papers, medical journals, certified publications, articles from recognized authors, directories, and databases such as Statista, Clinicaltrials.gov, American Association of Pharmaceutical Scientists (AAPS), Pharmaceutical Research and Manufacturers of America (PhRMA), NCBI, International Trade Administration (ITA), European Federation of Pharmaceutical Industries and Associations (EFPIA), whereas primary research included extensive interviews with key opinion leaders such as CEOs, directors, and marketing executives. The percentage splits, shares, and breakdowns of the segments were determined using secondary sources and verified through primary sources. This data is consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report.

Drug Discovery Informatics Market

To know about the assumptions considered for the study, download the pdf brochure

The key players operating in the drug discovery informatics market are IBM (US), Infosys Ltd. (India), Schrödinger (US), PerkinElmer (US), and Thermo Fisher Scientific (US).

Target Audience:

  • Providers drug discovery informatics solution
  • Pharmaceutical companies
  • Academic institutes
  • Biotechnology companies
  • Research institutes
  • Government associations
  • Contract research organizations (CROs)

Scope of the Report

The research report categorizes the global Drug Discovery Informatics Market into the following segments and sub segments:

  • by Process
    • Sequencing and Target Data Analysis
    • Docking
    • Molecular Modelling
    • Libraries & Database Preparation
    • Other Processes (Screening and ADMET characterization)
  • by Solution
    • Software
    • Services
  • by End User
    • Pharmaceutical & Biotechnology Companies
    • Contract Research Organizations (CROs)
    • Others (Academic Institutes, Government Organizations)
  • by Region
    • North America
      • US
      • Canada
    • Europe
      • Germany
      • RoE
    • Asia Pacific
    • Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographic Analysis

Further breakdown of the European market to UK, France, and Italy

The global drug discovery informatics market is expected to reach USD 2.84 Billion in 2022 from USD 1.67 Billion in 2017 at a CAGR of 11.2%. The pharmaceutical industry deals with a huge amount of data in the process of drug discovery. Moreover, it takes approximately 10 years to bring a drug to the market from the start of the discovery process and drug discovery alone accounts for approximately 4 years of that time frame. The complete process of drug development and commercialization can cost as much as USD 1 to 2 billion. With such huge investments at stake, drug discovery informatics can help target the right compound and avoid negative outcomes. Rising R&D expenditure across the globe, increasing focus on drug delivery, and the need to control drug discovery and development costs are the factors driving the growth of this market.

In this report, the market has been categorized based on function, solution, end user, and region. Based on function, the drug discovery informatics market is divided into sequencing and target data analysis, docking, molecular modeling, libraries & database preparation, and other functions. In 2017, the sequencing and target data analysis segment is expected to account for the largest share of the market. Factors such as the expansive application of informatics solutions in targeted analysis and the large amount of data generated during the drug discovery process are driving the growth of this segment.

On the basis of solution, the market is classified into software and services. In 2017, the software segment is expected to account for the largest share of the global drug discovery informatics market. The largest share of this segment is attributed to the fast and efficient management of data generated throughout the drug discovery process using discovery informatics software solutions.

In 2017, in terms of value, North America is expected to account for the largest share of the global drug discovery informatics market. Asia Pacific is expected to register the highest growth rate from 2017 to 2022. This can be attributed to the fastest-growing APAC pharmaceutical market in the world, the availability of many qualified researchers, and the low cost of human resources and manufacturing.

Drug Discovery Informatics Market

The scarcity of skilled professionals and the high pricing and setup cost of informatics software are the major factors expected to restrain market growth.

The key players in the drug discovery informatics market are IBM (US), Infosys (India), Schrödinger (US), PerkinElmer (US), and Thermo Fisher Scientific (US). These players focus on inorganic strategies such as acquisitions, agreements, and collaborations as well as organic strategies such as product launches and expansions to sustain their growth in the global market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 11)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 14)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
    2.4 Assumptions

3 Executive Summary (Page No. - 22)

4 Premium Insights (Page No. - 25)
    4.1 Drug Discovery Informatics: Market Overview
    4.2 Asia Pacific Drug Discovery Informatics Market, By Function and End User
    4.3 Drug Discovery Informatics Market, By Solution
    4.4 Geographical Snapshot of the Drug Discovery Informatics Market

5 Market Overview (Page No. - 28)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Rising R&D Expenditure
                    5.2.1.2 Increasing Focus on Drug Discovery
                    5.2.1.3 Need to Control Drug Discovery and Development Costs
           5.2.2 Restraint
                    5.2.2.1 High Pricing and Setup Cost of Informatics Software
           5.2.3 Opportunities
                    5.2.3.1 Patent Expiry
                    5.2.3.2 Growing Biotechnology Industry
           5.2.4 Challenge
                    5.2.4.1 Scarcity of Skilled Professionals

6 Drug Discovery Informatics Market, By Function (Page No. - 32)
    6.1 Introduction
    6.2 Sequencing & Target Data Analysis
    6.3 Docking
    6.4 Molecular Modelling
    6.5 Libraries & Database Preparation
    6.6 Other Functions

7 Drug Discovery Informatics Market, By Solution (Page No. - 42)
    7.1 Introduction
    7.2 Software
    7.3 Services

8 Drug Discovery Informatics Market, By End User (Page No. - 47)
    8.1 Introduction
    8.2 Pharmaceutical and Biotechnology Companies
    8.3 Contract Research Organizations (CROS)
    8.4 Other End Users

9 Drug Discovery Informatics Market, By Region (Page No. - 54)
    9.1 Introduction
    9.2 North America
           9.2.1 US
           9.2.2 Canada
    9.3 Europe
           9.3.1 Germany
           9.3.2 Rest of Europe
    9.4 Asia Pacific (APAC)
    9.5 Rest of the World

10 Competitive Landscape (Page No. - 72)
     10.1 Overview
     10.2 Ranking of Players, 2016
     10.3 Competitive Scenario
             10.3.1 Collaborations, Partnerships, Agreements, & Acquisitions
             10.3.2 Expansions
             10.3.3 Product Launches & Enhancements

11 Company Profiles (Page No. - 76)
(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*
     11.1 Jubilant Life Sciences
     11.2 IBM
     11.3 Infosys
     11.4 Thermo Fisher Scientific
     11.5 Perkinelmer
     11.6 Schrödinger
     11.7 Dassault Systèmes
     11.8 Charles River Laboratories
     11.9 Selvita
     11.10 Certara
     11.11 GVK Biosciences
     11.12 Collaborative Drug Discovery
     11.13 Openeye Scientific Software
     11.14 IO Informatics
     11.15 Novo Informatics

*Details on Marketsandmarkets View, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 105)
     12.1 Insights of Industry Experts
     12.2 Discussion Guide
     12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.4 Introducing RT: Real-Time Market Intelligence
     12.5 Available Customizations
     12.6 Related Reports
     12.7 Author Details


List of Tables (63 Tables)

Table 1 Drug Discovery Informatics Market, By Function, 2015–2022 (USD Million)
Table 2 Drug Discovery Informatics Market for Sequencing & Target Data Analysis, By Region, 2015–2022 (USD Million)
Table 3 North America: Drug Discovery Informatics Market for Sequencing & Target Data Analysis, By Country, 2015–2022 (USD Million)
Table 4 Europe: Drug Discovery Informatics Market for Sequencing & Target Data Analysis, By Country, 2015–2022 (USD Million)
Table 5 Drug Discovery Informatics Market for Docking, By Region, 2015–2022 (USD Million)
Table 6 North America: Drug Discovery Informatics Market for Docking, By Country, 2015–2022 (USD Million)
Table 7 Europe: Drug Discovery Informatics Market for Docking, By Country, 2015–2022 (USD Million)
Table 8 Drug Discovery Informatics Market for Molecular Modelling, By Region, 2015–2022 (USD Million)
Table 9 North America: Drug Discovery Informatics Market for Molecular Modelling, By Country, 2015–2022 (USD Million)
Table 10 Europe: Drug Discovery Informatics Market for Molecular Modelling, By Country, 2015–2022 (USD Million)
Table 11 Drug Discovery Informatics Market for Libraries & Database Preparation, By Region, 2015–2022 (USD Million)
Table 12 North America: Drug Discovery Informatics Market for Libraries & Database Preparation, By Country, 2015–2022 (USD Million)
Table 13 Europe: Drug Discovery Informatics Market for Libraries & Database Preparation, By Country, 2015–2022 (USD Million)
Table 14 Drug Discovery Informatics Market for Other Functions, By Region, 2015–2022 (USD Million)
Table 15 North America: Drug Discovery Informatics Market for Other Functions, By Country, 2015–2022 (USD Million)
Table 16 Europe: Drug Discovery Informatics Market for Other Functions, By Country, 2015–2022 (USD Million)
Table 17 Drug Discovery Informatics Market, By Solution, 2015–2022 (USD Million)
Table 18 Drug Discovery Informatics Market for Software, By Region, 2015–2022 (USD Million)
Table 19 North America: Drug Discovery Informatics Market for Software, By Country, 2015–2022 (USD Million)
Table 20 Europe: Drug Discovery Informatics Market for Software, By Country, 2015–2022 (USD Million)
Table 21 Drug Discovery Informatics Market for Services, By Region, 2015–2022 (USD Million)
Table 22 North America: Drug Discovery Informatics Market for Services, By Country, 2015–2022 (USD Million)
Table 23 Europe: Drug Discovery Informatics Market for Services, By Country, 2015–2022 (USD Million)
Table 24 Drug Discovery Informatics Market, By End User, 2015–2022 (USD Million)
Table 25 Drug Discovery Informatics Market for Pharmaceutical and Biotechnology Companies, By Region, 2015–2022 (USD Million)
Table 26 North America: Drug Discovery Informatics Market for Pharmaceutical and Biotechnology Companies, By Country, 2015–2022 (USD Million)
Table 27 Europe: Drug Discovery Informatics Market for Pharmaceutical and Biotechnology Companies, By Country, 2015–2022 (USD Million)
Table 28 Drug Discovery Informatics Market for CROS, By Region, 2015–2022 (USD Million)
Table 29 North America: Drug Discovery Informatics Market for CROS, By Country, 2015–2022 (USD Million)
Table 30 Europe: Drug Discovery Informatics Market for CROS, By Country, 2015–2022 (USD Million)
Table 31 Drug Discovery Informatics Market for Other End Users, By Region, 2015–2022 (USD Million)
Table 32 North America: Drug Discovery Informatics Market for Other End Users, By Country, 2015–2022 (USD Million)
Table 33 Europe: Drug Discovery Informatics Market for Other End Users, By Country, 2015–2022 (USD Million)
Table 34 Drug Discovery Informatics Market, By Region, 2015–2022 (USD Million)
Table 35 North America: Drug Discovery Informatics Market, By Country, 2015–2022 (USD Million)
Table 36 North America: Drug Discovery Informatics Market, By Function, 2015–2022 (USD Million)
Table 37 North America: Drug Discovery Informatics Market, By Solution, 2015–2022 (USD Million)
Table 38 North America: Drug Discovery Informatics Market, By End User, 2015–2022 (USD Million)
Table 39 US: Drug Discovery Informatics Market, By Function, 2015–2022 (USD Million)
Table 40 US: Drug Discovery Informatics Market, By Solution, 2015–2022 (USD Million)
Table 41 US: Drug Discovery Informatics Market, By End User, 2015–2022 (USD Million)
Table 42 Canada: Drug Discovery Informatics Market, By Function, 2015–2022 (USD Million)
Table 43 Canada: Drug Discovery Informatics Market, By Solution, 2015–2022 (USD Million)
Table 44 Canada: Drug Discovery Informatics Market, By End User, 2015–2022 (USD Million)
Table 45 Europe: Drug Discovery Informatics Market, By Country, 2015–2022 (USD Million)
Table 46 Europe: Drug Discovery Informatics Market, By Function, 2015–2022 (USD Million)
Table 47 Europe: Drug Discovery Informatics Market, By Solution, 2015–2022 (USD Million)
Table 48 Europe: Drug Discovery Informatics Market, By End User, 2015–2022 (USD Million)
Table 49 Germany: Drug Discovery Informatics Market, By Function, 2015–2022 (USD Million)
Table 50 Germany: Drug Discovery Informatics Market, By Solution, 2015–2022 (USD Million)
Table 51 Germany: Drug Discovery Informatics Market, By End User, 2015–2022 (USD Million)
Table 52 Rest of Europe: Drug Discovery Informatics Market, By Function, 2015–2022 (USD Million)
Table 53 Rest of Europe: Drug Discovery Informatics Market, By Solution, 2015–2022 (USD Million)
Table 54 Rest of Europe: Drug Discovery Informatics Market, By End User, 2015–2022 (USD Million)
Table 55 Asia Pacific: Drug Discovery Informatics Market, By Function, 2015–2022 (USD Million)
Table 56 Asia Pacific: Drug Discovery Informatics Market, By Solution, 2015–2022 (USD Million)
Table 57 Asia Pacific: Drug Discovery Informatics Market, By End User, 2015–2022 (USD Million)
Table 58 RoW: Drug Discovery Informatics Market, By Function, 2015–2022 (USD Million)
Table 59 RoW: Drug Discovery Informatics Market, By Solution, 2015–2022 (USD Million)
Table 60 RoW: Drug Discovery Informatics Market, By End User, 2015–2022 (USD Million)
Table 61 Collaborations, Partnerships, Agreements, & Acquisitions, 2015–2017
Table 62 Expansions, 2015–2017
Table 63 Product Launches & Enhancements, 2015–2017


List of Figures (25 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Bottom Up Approach
Figure 4 Top Down Approach
Figure 5 Drug Discovery Informatics Market, By Function, 2017 vs 2022 (USD Billion)
Figure 6 Drug Discovery Informatics Market, By Solution, 2017 vs 2022 (USD Billion)
Figure 7 Drug Discovery Informatics Market, By End User, 2017 vs 2022 (USD Billion)
Figure 8 Geographical Snapshot of Drug Discovery Informatics Market (2017-2022)
Figure 9 Rising Focus on Reducing Operational Costs—A Primary Growth Driver of The Drug Discovery Informatics Market
Figure 10 Software Segment Will Continue to Dominate The Drug Discovery Informatics Market in 2022
Figure 11 APAC Will Be The Fastest-Growing Market From 2017 to 2022
Figure 12 Drug Discovery Informatics Market: Drivers, Restraints, & Opportunities
Figure 13 Global Pharmaceutical R&D Spending, 2012–2022 (USD Billion)
Figure 14 Drug Discovery Informatics Function
Figure 15 North America: Drug Discovery Informatics Market Snapshot
Figure 16 Asia Pacific: Drug Discovery Informatics Market Snapshot
Figure 17 Companies Adopted Product Launches, Expansions, Collaborations, Partnerships, Agreements, and Acquisitions as Their Key Growth Strategy Between 2014-2017
Figure 18 Jubilant Life Sciences: Company Snapshot (2017)
Figure 19 IBM: Company Snapshot (2016)
Figure 20 Infosys: Company Snapshot (2016)
Figure 21 Thermo Fisher: Company Snapshot (2016)
Figure 22 Perkinelmer: Company Snapshot (2016)
Figure 23 Dassault Systèmes: Company Snapshot (2016)
Figure 24 Charles River Laboratories: Company Snapshot (2016)
Figure 25 Selvita: Company Snapshot (2016)


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
HIT 5838
Published ON
Dec, 2017
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Drug Discovery Informatics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved